The Development of a Modified Human IFN-α2b Linked to the Fc Portion of Human IgG1 as a Novel Potential Therapeutic for the Treatment of Hepatitis C Virus Infection von Jones, Tim D., Hanlon, Marian, Smith, Beverley J., Heise, Charles T., Nayee, Prakash D., Sanders, Deborah A., Hamilton, Anita, Sweet, Clive, Unitt, Esther, Alexander, Graeme, Lo, Kin-Ming, Gillies, Stephen D., Carr, Frank J., Baker, Matthew P.

Volltext

The development of a modified human IFN-alpha2b linked to the Fc portion of human IgG1 as a novel potential therapeutic for the treatment of hepatitis C virus infection von Jones, Tim D, Hanlon, Marian, Smith, Beverley J, Heise, Charles T, Nayee, Prakash D, Sanders, Deborah A, Hamilton, Anita, Sweet, Clive, Unitt, Esther, Alexander, Graeme, Lo, Kin-Ming, Gillies, Stephen D, Carr, Frank J, Baker, Matthew P

Volltext

The synthesis of novel matrix metalloproteinase inhibitors employing the Ireland-Claisen rearrangement von PRATT, L. M, BECKETT, R. P, LEWIS, C. N, MANGAN, M, MARTIN, F. M, MILLER, K, NAYEE, P, RICKETTS, M. L, THOMAS, W, TODD, R. S, WHITTAKER, M, BELLAMY, C. L, CORKILL, D. J, COSSINS, J, COURTNEY, P. F, DAVIES, S. J, DAVIDSON, A. H, DRUMMOND, A. H, HELFRICH, K

Volltext